Leveraging scale in precision oncology to measure pathway activation and detect genetic drivers in a large, real-world pan-cancer cohort

被引:0
|
作者
Drews, Joshua
Langer, Lee
Karaesman, Ezgi
MacKay, Matthew
Sedgewick, Andrew
Bell, Joshua
Guinney, Justin
Igartua, Catherine
机构
关键词
D O I
10.1158/1538-7445.AM2023-3148
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3148
引用
收藏
页数:2
相关论文
共 18 条
  • [1] Real-world genetic testing outcomes of pan-cancer testing for mismatch repair deficiency
    Chai, Teresa S.
    Rodgers-Fouche, Linda H.
    Walls, Jenna O.
    Mattia, Anthony R.
    Chung, Daniel C.
    CANCER, 2024, 130 (22) : 3888 - 3893
  • [2] A Prognostic Model Based on Nutritional Indexes for Patients With Pan-Cancer: A Real-World Cohort Study
    Zheng, Lin
    Yu, Qian-Qian
    Ruan, Wen-Bin
    Chen, Jin
    Deng, Qing-Hua
    Zhang, Ke
    Jiang, Xu-Li
    Jiang, Wen-Jun
    Cai, Dan-Na
    He, Chen-Jie
    Wang, Yu-Feng
    Jiang, Shen-Li
    Ye, Rui-Zhi
    You, Guang-Xian
    Ying, Rong-Biao
    Zhou, Zhi-Rui
    CANCER REPORTS, 2024, 7 (06)
  • [3] Validation of genomic and transcriptomic models of homologous recombination deficiency in a real-world pan-cancer cohort
    Benjamin D. Leibowitz
    Bonnie V. Dougherty
    Joshua S. K. Bell
    Joshuah Kapilivsky
    Jackson Michuda
    Andrew J. Sedgewick
    Wesley A. Munson
    Tushar A. Chandra
    Jonathan R. Dry
    Nike Beaubier
    Catherine Igartua
    Timothy Taxter
    BMC Cancer, 22
  • [4] Validation of genomic and transcriptomic models of homologous recombination deficiency in a real-world pan-cancer cohort
    Leibowitz, Benjamin D.
    Dougherty, Bonnie V.
    Bell, Joshua S. K.
    Kapilivsky, Joshuah
    Michuda, Jackson
    Sedgewick, Andrew J.
    Munson, Wesley A.
    Chandra, Tushar A.
    Dry, Jonathan R.
    Beaubier, Nike
    Igartua, Catherine
    Taxter, Timothy
    BMC CANCER, 2022, 22 (01)
  • [5] Analysis of genomic alterations in pan-cancer from a large real-world Chinese population.
    Dong, Zhouhuan
    Gao, Jie
    Zhu, Fengwei
    Gai, Fei
    Su, Wenqing
    Liang, Zhixin
    Tian, Xiaodong
    Shi, Huaiyin
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [6] Systematic pan-cancer analysis of mutation–treatment interactions using large real-world clinicogenomics data
    Ruishan Liu
    Shemra Rizzo
    Sarah Waliany
    Marius Rene Garmhausen
    Navdeep Pal
    Zhi Huang
    Nayan Chaudhary
    Lisa Wang
    Chris Harbron
    Joel Neal
    Ryan Copping
    James Zou
    Nature Medicine, 2022, 28 : 1656 - 1661
  • [7] Pan-cancer profiling of the effect of biopsied site on tumor mutational burden measurements in a real-world data cohort
    Papillon-Cavanagh, Simon
    Gao, Chuan
    Han, G. Celine
    Walsh, Alice M.
    CANCER RESEARCH, 2020, 80 (16)
  • [8] Systematic pan-cancer analysis of mutation-treatment interactions using large real-world clinicogenomics data
    Liu, Ruishan
    Rizzo, Shemra
    Waliany, Sarah
    Garmhausen, Marius Rene
    Pal, Navdeep
    Huang, Zhi
    Chaudhary, Nayan
    Wang, Lisa
    Harbron, Chris
    Neal, Joel
    Copping, Ryan
    Zou, James
    NATURE MEDICINE, 2022, 28 (08) : 1656 - +
  • [9] Impact of the STK11/KRAS co-mutation on the response to immunotherapy in a real-world pan-cancer cohort
    Olsen, Andrea
    Lebedeva, Alexandra
    Nosova, Polina
    Nikulin, Vladislav
    Sharova, Margarita
    Ignatova, Ekaterina
    Mileyko, Vladislav
    Ivanov, Maxim
    TUMORI JOURNAL, 2024, 110 (02): : 146 - 152
  • [10] Association of a ctDNA biomarker of treatment response with clinical outcomes in a real-world pan-cancer cohort treated with tyrosine kinase inhibitors
    Mitra, Akash
    Guittar, John
    Schwind, Regina
    Driessen, Terri
    Berginski, Matthew
    Lo, Christine
    Stein, Michelle M.
    Freaney, Jonathan
    Hyun, Seung Won
    Sangli, Chithra
    Sasser, Kate
    Nimeiri, Halla
    Chaudhuri, Aadel
    CANCER RESEARCH, 2024, 84 (06)